NCT03364621View on ClinicalTrials.gov

Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 29, 2017

Primary Completion Date

June 29, 2026

Study Completion Date

June 29, 2026

Conditions

Colorectal CancerColorectal Cancer MetastaticHepatic Metastases

Trial Locations (2)

V5Z 4E6

Vancouver Regional Cancer Centre, Vancouver

M5G 2M9

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors

collaborator

Terry Fox Research Institute

OTHER

collaborator

British Columbia Cancer Agency

OTHER

lead

University Health Network, Toronto

OTHER

NCT03364621 - Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy | Biotech Hunter | Biotech Hunter